New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients.
Citation: Cardiovascular Drugs & Therapy. 29(1):1-3, 2015 Feb.PMID: 25702643Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: *ATP Binding Cassette Transporter 1/me [Metabolism] | *Cholesterol/me [Metabolism] | *Hydroxymethylglutaryl-CoA Reductase Inhibitors/pd [Pharmacology] | *Lipoproteins, HDL/me [Metabolism] | *MicroRNAs/me [Metabolism] | *Simvastatin/pd [Pharmacology] | Animals | HumansYear: 2015ISSN:- 1573-7241
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 25702643 | Available | 25702643 |
English